NCT03807856View on ClinicalTrials.gov

Treating Acute Pancreatitis With Dabigatran, a Pilot Study

PHASE1TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

July 23, 2020

Study Completion Date

July 23, 2020

Conditions

Acute Pancreatitis

Interventions

DRUG

Dabigatran Etexilate Mesylate

Dabigatran 150mg BID for 3 days

OTHER

Standard of Care

Daily vital signs, lab work and one outpatient clinic visit

Trial Locations (1)

32224

Mayo clinic, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT03807856 - Treating Acute Pancreatitis With Dabigatran, a Pilot Study | Biotech Hunter | Biotech Hunter